Article
MOLECULAR ANALYSIS OF MITOCHONDRIAL COMPLEX I IN THE RESPONSIVENESS TO LEVODOPA IN PARKINSON’S DISEASE
2025-11-13
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Introduction</h4> Significant advances have been made in elucidating the pathophysiological mechanisms of Parkinson’s disease (PD). Levodopa remains the main therapeutic option — although it presents heterogeneous clinical benefits among patients. Mutations related to levodopa metabolic pathways have been investigated, but not for mtDNA. Since levodopa metabolism is highly dependent on ioni...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a23118e-ff79-5ac7-88cf-24d94450cdcd
- DOI
- 10.1101/2025.11.10.25339914
